T helper 3 cells (T<sub>h</sub>3) are a subset of T lymphocytes with immunoregulary and immunosuppressive functions, that can be induced by administration of foreign oral antigen. T<sub>h</sub>3 cells act mainly through the secretion of anti-inflammatory cytokine transforming growth factor beta (TGF-ò) and interleukin-10 (IL-10). T<sub>h</sub>3 have been described both in mice and human as CD4<sup>+</sup>FOXP3<sup>−</sup> regulatory T cells. T<sub>h</sub>3 cells were first described in research focusing on oral tolerance in the experimental autoimmune encephalitis (EAE) mouse model and later described as CD4<sup>+</sup>CD25<sup>−</sup>FOXP3<sup>−</sup>LAP<sup>+</sup> cells, that can be induced in the gut by oral antigen through T cell receptor (TCR) signalling.
The function of T helper cells generally is to mediate the immune response by secreting cytokines and interacting with B-cells to enhance or inhibit their activity. This is of particular importance in the gut as this is where the highest load of foreign material, food, is present. T<sub>h</sub>3 cells are involved in mucosal immunity and protecting mucosal surfaces in the gut from non-pathogenic non-self antigens. They mediate this non-inflammatory environment by secreting TGF-ò and IL-10. TGF-beta promotes the class switch to low concentrations of IgA which is noninflammatory. IgA does not usually activate the complement system and is not involved with phagocytosis. T<sub>h</sub>3 inhibits T<sub>h</sub>1 and T<sub>h</sub>2 cells.
T<sub>h</sub>3 cells have different cytokine requirements for their growth from CD25<sup>+</sup>CD4<sup>+</sup> T<sub>reg</sub> cells. The survival of CD25<sup>+</sup>CD4<sup>+</sup> T<sub>reg</sub> cells is dependent upon interleukin 2 (IL-2), while in vitro differentiation of T<sub>h</sub>3 cells is enhanced by TGF-ò, IL-4, and IL-10.
Findings suggest that T<sub>h</sub>3 cells are a different lineage from naturally arising CD25<sup>+</sup>CD4<sup>+</sup> T<sub>reg</sub> cells, but it is still unclear whether T<sub>h</sub>3 cells are the same as induced T<sub>reg</sub> cells because of the lack of a specific marker for T<sub>h</sub>3 cells. It was previously shown that TGF-ò was produced by intestinal dendritic cells, which has been considered to be the source of cytokines for the induction of T<sub>h</sub>3 cells in the intestine. Additionally, since TGF-ò production was induced by cytotoxic T-lymphocyte antigen 4 (CTLA-4), which is constitutively expressed on naturally arising T<sub>reg</sub> cells, it is possible that TGF-ò production from T<sub>reg</sub> cells through CTLA-4<sup>−</sup> mediated signaling may stimulate the differentiation of both induced T<sub>reg</sub> cells and T<sub>h</sub>3 cells.
T<sub>h</sub>3 cells are characterised as CD4<sup>+</sup>CD25<sup>−</sup>CD69<sup>+</sup>FOXP3-LAP<sup>+</sup> cells. Unlike the well characterised T regulatory (T<sub>reg</sub> ) cells, T<sub>h</sub>3 cells do not express transcription factor FOXP3. There is a lack of specific transcription factor for full and reliable recognition of the T<sub>h</sub>3 cell population.
Type II-lectin receptor CD69 is presented on cell surface shortly after activation. The presence of CD69 is not specific for T<sub>h</sub>3 cells, since it is expressed on other lymphocytes, mainly subsets that are tissue resident. The latency-associated peptide (LAP) noncovalently bounds TGF-ò and can be expressed by many cells of the immune system.
In tumors T<sub>h</sub>3 cells can express lymphocyte activation gene-3 (LAG3). T<sub>h</sub>3 cells produce vast amounts of TGF-ò and to a lesser degree also the anti-inflammatory cytokine interleukin 10 (IL-10). In colorectal cancer T<sub>h</sub>3 cells were described as 50 times more potent immune suppressors than the classical regulatory FOXP3<sup>+</sup> T lymphocytes and their functions was mainly mediated by secretion of suppressive cytokines.
LAG3 acts as a negative regulator of T cell activation and function and can also be expressed on NK cells and other T cells, than T<sub>h</sub>3. Because of its structural similarity to CD4, LAG3 can bind MHC class II molecules.
T<sub>h</sub>3 cells can be activated by TCR stimulation after the recognition of an antigen or induced from CD4+ T lymphocytes by TGF-ò in the presence of IL-10 and IL-4 cytokines.
T<sub>h</sub>3 participate in the regulation of the immune response via mechanisms independent on cell-to-cell contact. Secretion of anti-inflammatory cytokine TGF-ò by T<sub>h</sub>3 cells helps to maintain homeostasis in the gut and suppress exaggerated inflammatory and autoimmune responses in the body. TGF-ò is a crucial cytokine for maintaining the naturally occurring T<sub>reg</sub> cells, that suppress T<sub>h</sub>1 and T<sub>h</sub>2 immune functions. àT<sub>h</sub>3 cells can also directly suppress T<sub>h</sub>1 and T<sub>h</sub>2 cells by secretion of TGF-ò and provide help to B cells towards IgA secretion.